Chapter 19. Treatment of Cancer in Conjunction with Other Agents

  1. Sotiris Missailidis
  1. Gary Robert Smith

Published Online: 7 NOV 2008

DOI: 10.1002/9780470697047.ch19

Anticancer Therapeutics

Anticancer Therapeutics

How to Cite

Smith, G. R. (2008) Treatment of Cancer in Conjunction with Other Agents, in Anticancer Therapeutics (ed S. Missailidis), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470697047.ch19

Editor Information

  1. Department of Chemistry and Analytical Sciences, The Open University, Milton Keynes, UK

Author Information

  1. Perses Biosystems Ltd, Warwick, UK

Publication History

  1. Published Online: 7 NOV 2008
  2. Published Print: 21 NOV 2008

ISBN Information

Print ISBN: 9780470723036

Online ISBN: 9780470697047



  • cancer treatment and other agents;
  • Helicobacter pylori and chronic inflammation;
  • non steroidal anti-inflammatory drug (NSAID);
  • cancer progression suppression mechanisms;
  • Agency for Healthcare Research and Quality (AHRQ);
  • Angiotensin II (Ang II) peptide hormone;
  • AT1 receptor expression and increased invasiveness;
  • Ang II and AT1 receptor expression


This chapter contains sections titled:

  • Introduction

  • Non-steroidal Anti-inflammatory Drugs

  • Angiotensin-converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockade

  • Partners in Crime – Dealing with Co-infections

  • Discussion